420 related articles for article (PubMed ID: 17299088)
1. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.
Gardenghi S; Marongiu MF; Ramos P; Guy E; Breda L; Chadburn A; Liu Y; Amariglio N; Rechavi G; Rachmilewitz EA; Breuer W; Cabantchik ZI; Wrighting DM; Andrews NC; de Sousa M; Giardina PJ; Grady RW; Rivella S
Blood; 2007 Jun; 109(11):5027-35. PubMed ID: 17299088
[TBL] [Abstract][Full Text] [Related]
2. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
Olivera J; Zhang V; Nemeth E; Ganz T
Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275
[TBL] [Abstract][Full Text] [Related]
3. Fetal factors disrupt placental and maternal iron homeostasis in murine β-thalassemia.
Yu Y; Woloshun RR; Lee JK; Ebea PO; Zhu S; Nemeth E; Garrick LM; Garrick MD; Collins JF
Blood; 2023 Jul; 142(2):185-196. PubMed ID: 37146247
[TBL] [Abstract][Full Text] [Related]
4. Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.
Guo S; Casu C; Gardenghi S; Booten S; Aghajan M; Peralta R; Watt A; Freier S; Monia BP; Rivella S
J Clin Invest; 2013 Apr; 123(4):1531-41. PubMed ID: 23524968
[TBL] [Abstract][Full Text] [Related]
5. Identification of erythroferrone as an erythroid regulator of iron metabolism.
Kautz L; Jung G; Valore EV; Rivella S; Nemeth E; Ganz T
Nat Genet; 2014 Jul; 46(7):678-84. PubMed ID: 24880340
[TBL] [Abstract][Full Text] [Related]
6. The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry.
Castro-Mollo M; Gera S; Ruiz-Martinez M; Feola M; Gumerova A; Planoutene M; Clementelli C; Sangkhae V; Casu C; Kim SM; Ostland V; Han H; Nemeth E; Fleming R; Rivella S; Lizneva D; Yuen T; Zaidi M; Ginzburg Y
Elife; 2021 May; 10():. PubMed ID: 34002695
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.
Arezes J; Foy N; McHugh K; Quinkert D; Benard S; Sawant A; Frost JN; Armitage AE; Pasricha SR; Lim PJ; Tam MS; Lavallie E; Pittman DD; Cunningham O; Lambert M; Murphy JE; Draper SJ; Jasuja R; Drakesmith H
Blood; 2020 Feb; 135(8):547-557. PubMed ID: 31899794
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.
Tanzi E; Di Modica SM; Bordini J; Olivari V; Pagani A; Furiosi V; Silvestri L; Campanella A; Nai A
Am J Hematol; 2024 Jul; 99(7):1313-1325. PubMed ID: 38629683
[TBL] [Abstract][Full Text] [Related]
9. Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia.
Rivella S
Blood; 2019 Jan; 133(1):51-58. PubMed ID: 30401707
[TBL] [Abstract][Full Text] [Related]
10. A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic mice.
Wake M; Palin A; Belot A; Berger M; Lorgouilloux M; Bichon M; Papworth J; Bayliss L; Grimshaw B; Rynkiewicz N; Paterson J; Poindron A; Spearing E; Carter E; Hudson R; Campbell M; Petzer V; Besson-Fournier C; Latour C; Largounez A; Gourbeyre O; Fay A; Coppin H; Roth MP; Theurl I; Germaschewski V; Meynard D
Blood Adv; 2024 Apr; 8(8):1898-1907. PubMed ID: 38241484
[TBL] [Abstract][Full Text] [Related]
11. The interactions between ineffective erythropoiesis and ferroptosis in β-thalassemia.
Lin S; Zheng Y; Chen M; Xu L; Huang H
Front Physiol; 2024; 15():1346173. PubMed ID: 38468700
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Growth Differentiation Factor 15 Gene Expression by Curcumin in Patients with Beta-Thalassemia Intermedia.
Saeidnia M; Ghaderi A; Erfani M; Nowrouzi-Sohrabi P; Shokri M; Tamaddon G; Karimi M; Babashahi M
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213217
[TBL] [Abstract][Full Text] [Related]
13. Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice.
Duarte TL; Lopes M; Oliveira M; Santos AG; Vasco C; Reis JP; Antunes AR; Gonçalves A; Chacim S; Oliveira C; Porto B; Teles MJ; Moreira AC; Silva AMN; Schwessinger R; Drakesmith H; Henrique R; Porto G; Duarte D
Leukemia; 2024 Jan; 38(1):96-108. PubMed ID: 37857886
[TBL] [Abstract][Full Text] [Related]
14. Lactate administration improves laboratory parameters in murine models of iron overload.
Liu W; Wu Y; Wei H; Ma J; Feng W; Yang Q; Zhang S; Ganz T; Liu S
Blood; 2024 Mar; 143(11):1045-1049. PubMed ID: 38194678
[TBL] [Abstract][Full Text] [Related]
15. Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?
Longo F; Piga A
J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36079046
[TBL] [Abstract][Full Text] [Related]
16. Perturbations in lipid metabolism and gut microbiota composition precede cardiac dysfunction in a mouse model of thalassemia.
Liu Y; Fillebeen C; Forest A; Botta A; Varin TV; Marette A; Burelle Y; Des Rosiers C; Pantopoulos K; Sweeney G
FASEB J; 2023 Dec; 37(12):e23257. PubMed ID: 37902616
[TBL] [Abstract][Full Text] [Related]
17. The Role of Iron in Benign and Malignant Hematopoiesis.
Sinha S; Pereira-Reis J; Guerra A; Rivella S; Duarte D
Antioxid Redox Signal; 2021 Aug; 35(6):415-432. PubMed ID: 33231101
[No Abstract] [Full Text] [Related]
18. Inflammation alters iron distribution in bone and spleen in mice.
Chang J; Debreli Coskun M; Kim J
Metallomics; 2023 Oct; 15(10):. PubMed ID: 37738439
[TBL] [Abstract][Full Text] [Related]
19. Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis.
Guerra A; Parhiz H; Rivella S
Haematologica; 2023 Oct; 108(10):2582-2593. PubMed ID: 37345473
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone ameliorates ineffective erythropoiesis in a β-thalassemia intermedia mouse model.
Zhang H; Liu R; Fang Z; Nie L; Ma Y; Sun F; Mei J; Song Z; Ginzburg YZ; Liu J; Chen H
Blood Adv; 2024 Jun; ():. PubMed ID: 38861356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
